High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya.
about
Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence - a narrative reviewCombination HIV prevention interventions: the potential of integrated behavioral and biomedical approachesFactors Associated with Adherence and Concordance Between Measurement Strategies in an HIV Daily Oral Tenofovir/Emtricitibine as Pre-exposure Prophylaxis (Prep) Clinical Trial, Botswana, 2007-2010.Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trialWomen's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South AfricaTaking culture seriously in biomedical HIV prevention trials: a meta-synthesis of qualitative studies.Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns.Personalized Biobehavioral HIV Prevention for Women and Adolescent Girls.Sexual Behavior Patterns and PrEP Dosing Preferences in a Large Sample of North American Men Who Have Sex With Men.Systematic review of facility-based sexual and reproductive health services for female sex workers in AfricaPreventing HIV infection in women.Preferences for daily or intermittent pre-exposure prophylaxis regimens and ability to anticipate sex among HIV uninfected members of Kenyan HIV serodiscordant couplesPerspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa.The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.The Promise of Pre-Exposure Prophylaxis for Black Men Who Have Sex with Men: An Ecological Approach to Attitudes, Beliefs, and Barriers.Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measuresHigh interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudyChallenges in providing counselling to MSM in highly stigmatized contexts: results of a qualitative study from Kenya."You are wasting our drugs": health service barriers to HIV treatment for sex workers in Zimbabwe.Clinical Trial Design for HIV Prevention Research: Determining Standards of Prevention.Robust vaginal colonization of macaques with a novel vaginally disintegrating tablet containing a live biotherapeutic product to prevent HIV infection in women."Why should I take drugs for your infection?": outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria.Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya.Emerging themes for sensitivity training modules of African healthcare workers attending to men who have sex with men: a systematic review."How I Wish This Thing Was Initiated 100 Years Ago!" Willingness to Take Daily Oral Pre-Exposure Prophylaxis among Men Who Have Sex with Men in KenyaGetting PrEPared for HIV Prevention Navigation: Young Black Gay Men Talk About HIV Prevention in the Biomedical Era.The promise and peril of pre-exposure prophylaxis (PrEP): using social science to inform prep interventions among female sex workersPrioritizing Risk in Preparation for a Demonstration Project: A Mixed Methods Feasibility Study of Oral Pre-Exposure Prophylaxis (PREP) among Female Sex Workers in South IndiaKnowledge, Attitudes, and Experiences of HIV Pre-Exposure Prophylaxis (PrEP) Trial Participants in Botswana.Differences in Attitudes About HIV Pre-Exposure Prophylaxis Use Among Stimulant Versus Alcohol Using Men Who Have Sex with Men.Seasons of Risk: Anticipated Behavior on Vacation and Interest in Episodic Antiretroviral Pre-exposure Prophylaxis (PrEP) Among a Large National Sample of U.S. Men Who have Sex with Men (MSM).Familiarity with and Preferences for Oral and Long-Acting Injectable HIV Pre-exposure Prophylaxis (PrEP) in a National Sample of Gay and Bisexual Men in the U.S.Early Adopters: Correlates of HIV Chemoprophylaxis Use in Recent Online Samples of US Men Who Have Sex with Men.Implementation of pre-exposure prophylaxis for human immunodeficiency virus infection: progress and emerging issues in research and policy.PrEP implementation research in Africa: what is new?Adherence to post-exposure prophylaxis for non-forcible sexual exposure to HIV: a systematic review and meta-analysis."Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention.Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature.
P2860
Q26778293-38127CAC-709B-48C4-A9B3-95474710EE4BQ27005602-50A54B88-ECCB-49E7-A581-D9A996DDA75EQ27318158-2C843B37-CAA9-4FEE-9C02-53D377D1F5C4Q28533828-ACC1A13E-8D15-47BA-A5B4-2D94F6E8CE39Q28540042-5C653FB5-0760-48CB-9679-B8A9ADE3684DQ30202107-9E93F81A-966D-4E7C-A928-A476F57E147EQ30238750-DCE10DBE-F85B-4E8E-9B53-3364BD29D4D4Q30357818-2869562B-0478-4421-BBFC-95A8775482EFQ30698590-FC893AA0-13F5-4706-9B4E-E6284F38DEADQ33805502-2DAFEA6C-5292-40BB-8A8F-48706AD381E5Q33855156-265AEE94-78E9-4A28-A04C-6E0C12383CB5Q34021932-8BC53C25-C7BF-4954-B017-C5074A78115CQ34180615-3716A99C-D688-4EC9-AEDF-6F6A95F17FF3Q34180736-26A84B9D-E080-4A88-B626-6B20C65E8A91Q34528062-AFCB3D14-B307-4149-8E01-D284EEEC1E7BQ34675000-AA00F142-17F2-4E7A-9E4F-57B1EC20E203Q34681829-D5D7A638-ABA3-482F-BC8F-0095D03C7459Q34769418-23D57844-E209-4528-8700-21574AD8C6E6Q34881228-1FBE80B3-8011-4C49-B6E5-926CDAEDCE13Q35187148-B928F07B-59D0-4C80-89C9-85BBF33127E9Q35415972-171398F8-DD3C-4C7D-9914-052102DA452DQ35496515-92C97C3C-60FE-4209-806A-809560A44ADAQ35558232-98F89340-D644-48D2-A432-42426608E30CQ35593824-7A523889-C145-4CD3-88A8-ACC9C1EE7D17Q35988266-83D5AEB4-F400-48CA-916E-938ACD96AA15Q36006850-FD97042B-F2BD-45E6-8807-9A06387024D9Q36160177-8E9B5FA2-6C3B-411D-92B7-41F66A2A1342Q36202628-7F407935-8176-4211-BE7A-5B50F69B28E5Q36451510-A09D5962-1BDA-4225-973D-86BE8459DBA8Q36803999-626F6E7D-75F0-44CB-9F25-163323117899Q36863426-FDD5AFAB-44B3-4CCF-A8C0-081D8209FE5BQ36995428-AE25799B-FC8C-4E71-AE5B-B3E6C89C5153Q36998543-7C632D83-4CDD-4E36-B119-3BDCBFD76D18Q37352568-587D9480-F192-42A8-92BB-24A7B277F439Q37352576-9F5D534F-1394-4230-B21F-3C902505410BQ37395830-19381449-8D2C-4DD8-BDE9-A9AF83F3ACACQ37500910-2A0337BD-030A-484A-A282-5917D7219BD8Q37526187-0648401F-0C23-42B2-B7CD-E9198AEF71C7Q37736062-17CDF72E-06C5-439A-8360-17F66143B550Q37736077-639FD7E4-3CDC-4CDE-AA49-6880347AFFCE
P2860
High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
High acceptability of HIV pre- ...... at-risk populations in Kenya.
@en
type
label
High acceptability of HIV pre- ...... at-risk populations in Kenya.
@en
prefLabel
High acceptability of HIV pre- ...... at-risk populations in Kenya.
@en
P2093
P2860
P1433
P1476
High acceptability of HIV pre- ...... at-risk populations in Kenya.
@en
P2093
Caroline Kuo
Don Operario
Eduard Joachim Sanders
Elisabeth Maria Van der Elst
Frances Priddy
Gaudensia Mutua
Jennifer Kanungi
Jessica Haberer
Judie Mbogua
Peter Mugo
P2860
P2888
P304
P356
10.1007/S10461-012-0317-8
P577
2013-07-01T00:00:00Z